In some elderly patients, levothyroxine may be linked with increased mortality

Treating some elderly people with levothyroxine may put them at increased risk of death, new research from Israel reports. The results will be presented on Tuesday, March 20, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.

"In patients who are 65 years of age or above with subclinical hypothyroidism and (TSH) <10 mIU/L (milli-international units per liter), treatment with is associated with significantly increased mortality," said lead study author Joseph Meyerovitch, M.D., professor and senior physician at the Jesse and Sara Lea Shafer Institute for Endocrinology and Diabetes of the Schneider Children's Medical Center of Israel in Petah Tikva, and Chief Pediatrician Medicine Wings, Community Division, Clalit Health Services, Tel Aviv, Israel

"Subclinical hypothyroidism, the situation when thyroid function is not normal but is not defined as a disease, is very common," he added. "Physicians should consider the results of the study before they begin treatment with levothyroxine in individuals 65 years of age and above who have subclinical hypothyroidism and TSH values under 10 mIU/L."

Meyerovitch and colleagues determined which patients 65 years or older with TSH levels between 4.2 and 10 mIU/L died during the years 2012 through 2016 (cases) and matched them with individuals who did not die during that period (controls).

The authors matched the patients according to age, gender, Charlson comorbidity index, TSH testing date, follow-up duration, and TSH quartile, and they compared the use of levothyroxine between the groups. They excluded all with known thyroid disease and those who had received anti-thyroid medications or glucocorticoids in the year before they were tested for TSH.

During the follow-up period, 419 people who died were matched with 1,558 people who did not die. Treatment with levothyroxine was linked with significantly increased mortality (hazard ratio = 1.19).

Factors associated with included age, senile dementia, congestive heart failure, cerebrovascular disease, and chronic renal failure. Femoral fractures and atrial fibrillation after beginning to take levothyroxine were not more prevalent in individuals who died during follow-up.


Explore further

Some patients on levothyroxine have continued symptoms

Citation: In some elderly patients, levothyroxine may be linked with increased mortality (2018, March 20) retrieved 22 August 2019 from https://medicalxpress.com/news/2018-03-elderly-patients-levothyroxine-linked-mortality.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
96 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more